Mag-aso, Gracelyn G.
HRN: 24-99-82 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2024
METRONIDAZOLE 500MG (TAB)
05/18/2024
05/25/2024
ORAL
500mg/tab
TID
Intestinal Amoebiasis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes